tiprankstipranks
IN8bio suspends patient enrollment in INB-400, to focus on INB-100
PremiumThe FlyIN8bio suspends patient enrollment in INB-400, to focus on INB-100
3M ago
IN8bio to reduce workforce by 49%
Premium
The Fly
IN8bio to reduce workforce by 49%
3M ago
IN8bio downgraded to Hold from Buy at JonesResearch
Premium
The Fly
IN8bio downgraded to Hold from Buy at JonesResearch
3M ago
IN8bio presents updated data from Phase 1 trial of INB-100 at EHA
PremiumThe FlyIN8bio presents updated data from Phase 1 trial of INB-100 at EHA
5M ago
IN8bio presents PFS update from Phase 1 study of INB-200
Premium
The Fly
IN8bio presents PFS update from Phase 1 study of INB-200
6M ago
IN8bio announces multiple presentations at ISCT 2024
Premium
The Fly
IN8bio announces multiple presentations at ISCT 2024
6M ago
INAB Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsINAB Upcoming Earnings Report: What to Expect?
7M ago
IN8bio begins dosing in Phase 2 trial of INB-400 in newly diagnosed glioblastoma
Premium
The Fly
IN8bio begins dosing in Phase 2 trial of INB-400 in newly diagnosed glioblastoma
7M ago
IN8bio: Data for Gamma-Delta nsCAR-T cell therapy platform presented at AACR
Premium
The Fly
IN8bio: Data for Gamma-Delta nsCAR-T cell therapy platform presented at AACR
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100